<?xml version="1.0" ?>
<TABLE>
<ENTRY>
<ID>CHEBI:15859</ID>
<NAME>N-carbamoyl-L-aspartic acid</NAME>
<DEFINITION>The L-enantiomer N-carbamoylaspartic acid.</DEFINITION>
<STAR>3</STAR>
<SECONDARY_ID>CHEBI:44316</SECONDARY_ID>
<SECONDARY_ID>CHEBI:12496</SECONDARY_ID>
<SECONDARY_ID>CHEBI:7257</SECONDARY_ID>
<SECONDARY_ID>CHEBI:21688</SECONDARY_ID>
<SYNONYM>N-carbamoyl-S-aspartic acid</SYNONYM>
<SYNONYM>N-CARBAMOYL-L-ASPARTATE</SYNONYM>
<SYNONYM>N-Carbamoyl-L-aspartate</SYNONYM>
<SYNONYM>N-(aminocarbonyl)-L-aspartic acid</SYNONYM>
<SYNONYM>L-ureidosuccinic acid</SYNONYM>
<SYNONYM>Carbamyl-L-aspartic acid</SYNONYM>
<SYNONYM>carbamyl-L-aspartic acid</SYNONYM>
<IUPAC_NAME>N-carbamoyl-L-aspartic acid</IUPAC_NAME>
<FORMULA>C5H8N2O5</FORMULA>
<MASS>176.12740</MASS>
<MONOISOTOPIC_MASS>176.043</MONOISOTOPIC_MASS>
<CHARGE>0</CHARGE>
<SMILES>NC(=O)N[C@@H](CC(O)=O)C(O)=O</SMILES>
<INCHI>InChI=1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)/t2-/m0/s1</INCHI>
<INCHIKEY>HLKXYZVTANABHZ-REOHCLBHSA-N</INCHIKEY>
<BEILSTEIN_REGISTRY_NUMBER>1726860</BEILSTEIN_REGISTRY_NUMBER>
<CAS_REGISTRY_NUMBER>13184-27-5</CAS_REGISTRY_NUMBER>
<REAXYS_REGISTRY_NUMBER>1726860</REAXYS_REGISTRY_NUMBER>
<CHEMIDPLUS>13184-27-5</CHEMIDPLUS>
<DRUGBANK_ACCESSION>DB04252</DRUGBANK_ACCESSION>
<HMDB_ACCESSION>HMDB0000828</HMDB_ACCESSION>
<KEGG_COMPOUND_ACCESSION>C00438</KEGG_COMPOUND_ACCESSION>
<KNAPSACK_ACCESSION>C00007265</KNAPSACK_ACCESSION>
<PDBECHEM_ACCESSION>NCD</PDBECHEM_ACCESSION>
<WIKIPEDIA_ACCESSION>Carbamoyl_aspartic_acid</WIKIPEDIA_ACCESSION>
<PUBMED_CITATION>17439666</PUBMED_CITATION>
</ENTRY>
</TABLE>
